NDC 13744-505-32 - MELOXIDYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13744-505
- Requested NDC
- 13744-505-32
- Package NDCs from labels
- 13744-505-01, 13744-505-32, 13744-505-10, 13744-505-20
- Manufacturer
- Ceva Sante Animale
- Effective date
- 2025-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MELOXIDYL - Ceva Sante Animale | Ceva Sante Animale | 2025-07-30 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13744-505-01 | MELOXIDYL | 10 mL in 1 BOTTLE | SUSPENSION | 10 | 8 | |
| 13744-505-01 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-10 | MELOXIDYL | 100 mL in 1 BOTTLE | SUSPENSION | 100 | 8 | |
| 13744-505-10 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-20 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-20 | MELOXIDYL | 200 mL in 1 BOTTLE | SUSPENSION | 200 | 8 | |
| 13744-505-32 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-32 | MELOXIDYL | 32 mL in 1 BOTTLE | SUSPENSION | 32 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MELOXICAM | ACTIVE INGREDIENT | VG2QF83CGL | MELOXIDYL (MELOXICAM) SUSPENSION [CEVA SANTE ANIMALE] | 2 | |
| MELOXICAM | ACTIVE MOIETY | VG2QF83CGL | MELOXIDYL (MELOXICAM) SUSPENSION [CEVA SANTE ANIMALE] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 9392df66-a152-40e6-b43b-44dc46a23496 | 2021-08-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 10c3949c-0066-4b8a-8d35-937e1ce09bf8 | 2021-08-06 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 8f43b954-d1cb-4210-b479-5292c446cc74 | 2021-05-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 966ae650-ad7d-4de1-ab06-54992408fcfd | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 | 2020-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Exelan Pharmaceuticals Inc. | dfaac71c-dcc5-4b57-bf3b-616fccab96de | 2018-09-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.